Trial Profile
Effect of teneligliptin in patients with type 2 diabetes and receiving DPP-4 inhibitors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2015
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 May 2015 New trial record